Biomarkers of oxidative stress following continuous positive airway pressure withdrawal: Data from two randomised trials

European Respiratory Journal

Volumn 46, Issue 4, 2015, Pages 1065-1071

  Stradling, John R ^a   Schwarz, Esther I ^b   Schlatzer, Christian ^b   Manuel, Ari R ^a   Lee, Regent ^c   Antoniades, Charalambos ^c   Kohler, Malcolm ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ISOPROSTANE DERIVATIVE; LIPID HYDROPEROXIDE; MALONALDEHYDE; SUPEROXIDE; SUPEROXIDE DISMUTASE; ANTIOXIDANT; HYDROGEN PEROXIDE; LIPID; OXYGEN;

ADULT; ANALYTICAL PARAMETERS; CONFERENCE PAPER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONONUCLEAR CELL; OUTCOME ASSESSMENT; OXIDATIVE STRESS; OXYGEN DESATURATION INDEX; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; TOTAL ANTIOXIDANT CAPACITY; TREATMENT WITHDRAWAL; AGED; BLOOD; CHEMISTRY; HYPOXIA; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SLEEP APNEA, OBSTRUCTIVE; STATISTICAL MODEL; URINE; YOUNG ADULT;

ADULT; AGED; ANTIOXIDANTS; BIOMARKERS; CONTINUOUS POSITIVE AIRWAY PRESSURE; F2-ISOPROSTANES; FEMALE; HUMANS; HYDROGEN PEROXIDE; HYPOXIA; LEUKOCYTES, MONONUCLEAR; LINEAR MODELS; LIPIDS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; OXYGEN; SLEEP APNEA, OBSTRUCTIVE; SUPEROXIDE DISMUTASE; SUPEROXIDES; YOUNG ADULT;

EID: 84943231281     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00023215     Document Type: Conference Paper

References (37)

1. Kohler M, Stoewhas AC, Ayers L, et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 2011; 184: 1192-1199.
2. Kohler M, Craig S, Pepperell JC, et al. CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial. Chest 2013; 144: 896-902.
3. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359: 204-210.
4. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053.
5. Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 2010; 7: 677-685.
6. Kohler M, Pepperell JC, Casadei B, et al. CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 2008; 32: 1488-1496.
7. Lavie L, Polotsky V. Cardiovascular aspects in obstructive sleep apnea syndrome - molecular issues, hypoxia and cytokine profiles. Respiration 2009; 78: 361-370.
8. Sert Kuniyoshi FH, Singh P, Gami AS, et al. Patients with obstructive sleep apnea exhibit impaired endothelial function after myocardial infarction. Chest 2011; 140: 62-67.
9. Sitia S, Tomasoni L, Atzeni F, et al. From endothelial dysfunction to atherosclerosis. Autoimmun Rev 2010; 9: 830-834.
10. Kohler M, Stradling JR. CrossTalk proposal: most of the cardiovascular consequences of OSA are due to increased sympathetic activity. J Physiol 2012; 590: 2813-2815.
11. Lavie L, Lavie P. CrossTalk opposing view: most cardiovascular diseases in sleep apnoea are not caused by sympathetic activation. J Physiol 2012; 590: 2817-2819.
12. Garvey JF, Taylor CT, McNicholas WT. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 2009; 33: 1195-1205.
13. Badran M, Ayas N, Laher I. Cardiovascular complications of sleep apnea: role of oxidative stress. Oxid Med Cell Longev 2014; 2014: 985258.
14. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
15. Hoffmann MS, Singh P, Wolk R, et al. Obstructive sleep apnea and intermittent hypoxia increase expression of dual specificity phosphatase 1. Atherosclerosis 2013; 231: 378-383.
16. Polak J, Shimoda LA, Drager LF, et al. Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposure. Sleep 2013; 36: 1483-1490.
17. Brugniaux JV, Pialoux V, Foster GE, et al. Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans. Eur Respir J 2011; 37: 880-887.
18. Katsoulis K, Kontakiotis T, Spanogiannis D, et al. Total antioxidant status in patients with obstructive sleep apnea without comorbidities: the role of the severity of the disease. Sleep Breath 2011; 15: 861-866.
19. Stepanyan V, Crowe M, Haleagrahara N, et al. Effects of vitamin E supplementation on exercise-induced oxidative stress: a meta-analysis. Appl Physiol Nutr Metab 2014; 39: 1029-1037.
20. Moon GJ, Kim SJ, Cho YH, et al. Antioxidant effects of statins in patients with atherosclerotic cerebrovascular disease. J Clin Neurol 2014; 10: 140-147.
21. Antoniades C, Bakogiannis C, Tousoulis D, et al. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity. Circulation 2010; 122: S66-S73.
22. Lykkesfeldt J. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 2007; 380: 50-58.
23. Park AM, Nagase H, Kumar SV, et al. Effects of intermittent hypoxia on the heart. Antioxid Redox Signal 2007; 9: 723-729.
24. Heusch G, Bøtker HE, Przyklenk K, et al. Remote ischemic conditioning. J Am Coll Cardiol 2015; 65: 177-195.
25. Almendros I, Wang Y, Gozal D. The polymorphic and contradictory aspects of intermittent hypoxia. Am J Physiol Lung Cell Mol Physiol 2014; 307: L129-L140.
26. Ozeke O, Ozer C, Gungor M, et al. Chronic intermittent hypoxia caused by obstructive sleep apnea may play an important role in explaining the morbidity-mortality paradox of obesity. Med Hypotheses 2011; 76: 61-63.
27. Shah N, Redline S, Yaggi HK, et al. Obstructive sleep apnea and acute myocardial infarction severity: ischemic preconditioning? Sleep Breath 2013; 17: 819-826.
28. Chen CF, Tsai SY, Ma MC, et al. Hypoxic preconditioning enhances renal superoxide dismutase levels in rats. J Physiol 2003; 552: 561-569.
29. Lavie L. Oxidative stress in obstructive sleep apnea and intermittent hypoxia - revisited - the bad ugly and good: implications to the heart and brain. Sleep Med Rev 2015; 20: 27-45.
30. Yamauchi M, Nakano H, Maekawa J, et al. Oxidative stress in obstructive sleep apnea. Chest 2005; 127: 1674-1679.
31. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004; 27: 123-128.
32. Carpagnano GE, Kharitonov SA, Resta O, et al. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 2003; 124: 1386-1392.
33. Svatikova A, Wolk R, Lerman LO, et al. Oxidative stress in obstructive sleep apnoea. Eur Heart J 2005; 26: 2435-2439.
34. Wali SO, Bahammam AS, Massaeli H, et al. Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep 1998; 21: 290-296.
35. Alonso-Fernández A, García-Río F, Arias MA, et al. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 2009; 64: 581-586.
36. Savransky V, Bevans S, Nanayakkara A, et al. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 2007; 293: G871-G877.
37. Polotsky VY, Savransky V, Bevans-Fonti S, et al. Intermittent and sustained hypoxia induce a similar gene expression profile in human aortic endothelial cells. Physiol Genomics 2010; 41: 306-314.